![An Overview of Current Medication Responses to COVID-19 - Physician's Channel - Mount Sinai New York An Overview of Current Medication Responses to COVID-19 - Physician's Channel - Mount Sinai New York](http://res.cloudinary.com/broadcastmed/image/fetch/q_auto,c_fill,w_1300,h_731,g_faces:center,f_auto/http%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2ForlVideoAssets%2FimgSource%2Fscreen-shot-2020-06-01-at-1.28.12-pm.png)
An Overview of Current Medication Responses to COVID-19 - Physician's Channel - Mount Sinai New York
![Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos](https://www.pacientesenbuenasmanos.com/wp-content/uploads/2015/05/cordon-cardo-644x362.jpg)
Carlos Cordón-Cardó: "Con una dosis única de radiación contra el tumor reducimos la toxicidad al 1%" - Pacientes en Buenas ManosPacientes en Buenas Manos
![El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE](https://cope-cdnmed.agilecontent.com/resources/jpg/7/3/1649071127237.jpg)
El Dr. Carlos Cordón-Cardó y el gallego José Tubío, premios Ramiro Carregal de Investigación Oncológica - Santiago - COPE
![Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly | Mount Sinai - New York Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2020/MSHS-Carlos-Newsroom-770x420.jpg)
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly | Mount Sinai - New York
Carlos Cordon-Cardo - Professor and Chairman, Department of Pathology, Molecular and Cell Based Medicine - Mount Sinai Health System | LinkedIn
![Icahn School of Medicine at Mount Sinai on Twitter: "Carlos Cordon-Cardo, MD, PhD, Professor and Chairman of the Department of Pathology, as an NAI Fellow, was selected as an NAI Fellow by Icahn School of Medicine at Mount Sinai on Twitter: "Carlos Cordon-Cardo, MD, PhD, Professor and Chairman of the Department of Pathology, as an NAI Fellow, was selected as an NAI Fellow by](https://pbs.twimg.com/media/FkglGm3WQAEA05q.jpg)
Icahn School of Medicine at Mount Sinai on Twitter: "Carlos Cordon-Cardo, MD, PhD, Professor and Chairman of the Department of Pathology, as an NAI Fellow, was selected as an NAI Fellow by
![Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course | Mount Sinai - New York Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2020/MSHS-Newsroom-EndtoEnd-2col-770x420.jpg)